Krishna Komanduri, Medical Director, Living Therapeutics Initiative at University of California, San Francisco, shared on LinkedIn:
“I always feel like a proud American when going to Capitol Hill to advocate for the needs of cancer patients, their families and our academic health systems.
Thrilled to represent the ASTCT today including advocacy for funding and autonomy for the The National Institutes of Health and for ongoing funding for the CW Bill Young Act and its support for the NMDP.”
Other articles featuring Krishna Komanduri on OncoDaily.